2014
DOI: 10.3109/15563650.2014.965828
|View full text |Cite
|
Sign up to set email alerts
|

An 11-year review of levetiracetam ingestions in children less than 6 years of age

Abstract: Pediatric levetiracetam exposures were associated with few transient clinical effects. Poison Control Centers may wish to consider acuity of ingestion when developing send-in protocols.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 9 publications
0
8
0
Order By: Relevance
“…Chart review for symptomatology focused on clinical signs and symptoms documented in the patient medical record that may have been associated with drug toxicity. This is a similar approach to other retrospective investigations of lamotrigine and levetiracetam toxicity [ 10 , 14 , 35 ]. Clinical signs and symptoms were considered as possibly representative of drug toxicity if they were distinct from baseline level of function (or at least a worsening of previous function) and causally connected to drug exposure.…”
Section: Methodsmentioning
confidence: 90%
“…Chart review for symptomatology focused on clinical signs and symptoms documented in the patient medical record that may have been associated with drug toxicity. This is a similar approach to other retrospective investigations of lamotrigine and levetiracetam toxicity [ 10 , 14 , 35 ]. Clinical signs and symptoms were considered as possibly representative of drug toxicity if they were distinct from baseline level of function (or at least a worsening of previous function) and causally connected to drug exposure.…”
Section: Methodsmentioning
confidence: 90%
“…Levetiracetam (LEV) is generally considered a well‐tolerated drug that does not require routine laboratory monitoring. Maximum recommended doses are 42 mg/kg in infants younger than 6 months, 50 mg/kg in children aged 6 months to 4 years and 60 mg/kg in those older than 4 years old . T max is 1 h, therapeutic range is 12–46 mg/L, and T ½ is 6–8 h …”
Section: Levetiracetammentioning
confidence: 99%
“…In a large paediatric sample, most patients were asymptomatic. Symptomatic patients experienced drowsiness, lethargy, vertigo and, less commonly, ataxia, agitation, irritability, seizures, vomiting and tachycardia …”
Section: Levetiracetammentioning
confidence: 99%
See 2 more Smart Citations